Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer

Recruiting now

Conditions studied: Breast Neoplasms

In brief

This study evaluates the genomic profiles of breast cancer in a prospective and population-based manner. In the first phase, breast tumors are analyzed by whole transcriptome RNA-sequencing. Gene expression profiles, mutational profiles, and transcript isoform-level data will be analyzed in the context of patient information, clinicopathological variables, and outcome, with the purpose to develop new molecular diagnostic assays for breast cancer. Additional genome-scale RNA, DNA, and protein analyses will be performed in the future.

Key facts

Study ID

NCT02306096

Run by

Lund University

People needed

20000

Starts

2010-08-01

Expected to finish

2031-08-01

Last updated by the study team

2024-02-09

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• suspicion or confirmed diagnosis of primary breast cancer
• signed informed consent

You may not qualify if…

• lack of signed informed consent

Where it is running

• Central Hospital Växjö — Vaxjo, Sweden (enrolling)
• Helsingborg Hospital — Helsingborg, Sweden (enrolling)
• Kirurgiska kliniken — Jönköping, Sweden (enrolling)
• Blekinge County Hospital — Karlskrona, Sweden (enrolling)
• Central Hospital Kristianstad — Kristianstad, Sweden (enrolling)
• Skåne University Hospital — Lund, Sweden (enrolling)
• Skåne University Hospital — Malmö, Sweden (enrolling)
• Uppsala University Hospital — Uppsala, Sweden (enrolling)
• Hallands Hospital Halmstad — Halmstad, Sweden

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.